Publisher: Daniel Carlat, MD

Editor-in-Chief: Noah Capurso, MD, MHS

Deputy Editor: Talia Puzantian, PharmD, BCPP, professor at the Keck Graduate Institute School of Pharmacy in Claremont, CA.

Executive Editor: Janice Jutras

Assistant Editor: Ilana Fogelson

Editorial Contributors: Mara Storto, MD; Deepti Anbarasan, MD

Founding Editor: David A. Frenz, MD, medical director of addiction medicine at HealthEast Care System in St. Paul, MN.

Editorial Board

Bachaar Arnaout, MD, assistant clinical professor of psychiatry at the Yale School of Medicine.

Sandra Gomez-Luna, MD, clinical assistant professor at Yale University. Adult, adolescent, and child psychiatrist in Darien, CT.

Travis M. Lajoie, DO, adjunct assistant professor at the University of Utah School of Medicine and medical director of inpatient psychiatry at the George E. Wahlen Department of Veterans Affairs Medical Center.

Timothy J. Legg, PhD, PsyD, MSN, psychiatric mental health nurse practitioner at Offices of Psychiatry & Counseling Services, Matthew A. Berger, MD, PC, Moosic, PA. Licensed psychologist in private practice, Binghamton, NY.

Ben Oldfield, MD, clinical instructor at Yale University and Chief Medical Officer at Fair Haven Community Health Care. New Haven, CT.

David Stiffler, MD, HS Clinical Assistant Professor and Associated Program Director, Addiction Psychiatry Fellowship, UCSD Department of Psychiatry.

Mikveh Warshaw, NP, psychiatric mental health nurse practitioner, Community Health Center Inc. and faculty member of Center for Key Populations (CKP) Program, Middletown, CT.

Michael Weaver, MD, FASAM, professor and medical director at the Center for Neurobehavioral Research on Addictions at the University of Texas Medical School.

All editorial content is peer reviewed by the editorial board. Dr. Carlat, Dr. Capurso, Dr. Puzantian, Ms. Jutras, Ms. Fogelson, Dr. Frenz, Dr. Arnaout, Dr. Gomez-Luna, Dr. Lajoie, Dr. Legg, Dr. Oldfield, Dr. Stiffler, Dr. Warshaw, and Dr. Weaver have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity. This CE/CME activity is intended for psychologists, social workers, psychiatrists, and other mental health professionals with an interest in the diagnosis and treatment of addictive disorders.

As of June 2021